Doctor Takahiro Noto
Sapporo Medical University, Sapporo (Japan)
Early commencement of tolvaptan therapy improves clinical outcomes in heart failure patients with preserved function of renal vasopressin V2 receptors
Event: ESC Congress 2018
Topic: Pharmacotherapy
Session: Chronic heart failure – Treatment
ESC 365 is supported by
